At a glance
ClinicalIndex Comparison RecordN/ACompleted· 5 enrolled
Drug / intervention
plasma treatmentdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Single Center Open Label Early Feasibility Study to Evaluate the Efficacy and Safety of the RenewalNail™ Plasma Treatment System in Patients With Mild to Moderate Onychomycosis (Fungal Nail) of the Hallux Caused by Trichophyton Rubrum or Trichophyton Mentagrophytes.
In Brief
A clinical study evaluating plasma treatment for Onychomycosis of Toenail and Onychomycosis. Completed, enrolled 5 participants across 1 site.
Detailed Summary
A study to determine if a three-treatment protocol with the RenewalNail™ plasma treatment system over a week will result in mycological cure and/or clear nail growth on the treated hallux toe.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOnychomycosis of Toenail, Onychomycosis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartJul 2017
First PostedJul 2017
Primary CompletionJun 2018
Study CompletionJul 2018
TodayJul 2026
First PostedJul 13, 2017
Enrollment StartJul 7, 2017
Primary CompletionJun 30, 2018
Study CompletionJul 10, 2018
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 9.0 years ago
Interventions
plasma treatmentdevice
application of cold atmospheric plasma to a fungal infected toenail